
|Articles|November 1, 2001
FDA working to speed up alerts
Recognizing the slow process by which the FDA alerts companies to recallprescription drugs and other products, the agency is working to streamlineits procedures.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Spotlight on women's health: Understanding thyroid eye disease
2
Seeing the difference: Multimodal imaging for AMD and GA
3
Dompé enrolls first patients in phase 3 study of isocyclosporin for treatment of atopic keratoconjunctivitis
4
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
5








































